Item 9 Labs Corp.
INLB
$0.00
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -73.01% | -4.88% | 82.34% | -237.25% | -41.06% |
| Total Depreciation and Amortization | -2.19% | -0.14% | -13.41% | 2.57% | 6.19% |
| Total Amortization of Deferred Charges | -0.40% | -0.81% | -66.28% | 156.44% | -20.93% |
| Total Other Non-Cash Items | 53.12% | 429.84% | -98.85% | 961.77% | -16.02% |
| Change in Net Operating Assets | 96.48% | 143.06% | -78.85% | 367.54% | -56.45% |
| Cash from Operations | -50.40% | 122.67% | -460.29% | 90.03% | -472.56% |
| Capital Expenditure | -4,286.67% | 122.06% | 99.52% | -545.15% | 142.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 95.29% | -8.36% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 697.22% | 99.80% |
| Cash from Investing | -4,286.67% | 122.06% | 99.51% | -672.30% | 109.44% |
| Total Debt Issued | 2,093.60% | -100.78% | -25.11% | -35.40% | 33.10% |
| Total Debt Repaid | 6.13% | 33.67% | 64.50% | 14.80% | -20.74% |
| Issuance of Common Stock | -- | -- | -- | -61.85% | -7.51% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -120.22% | -62.94% |
| Cash from Financing | 97.77% | -117.59% | 0.37% | -48.75% | 32.35% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.65% | 224.26% | 82.05% | -205.79% | 705.22% |